Skip to content

Platelet rich plasma (PRP) for the treatment of chronic refractory wounds

Study on the clinical efficacy of platelet rich plasma (PRP) in the treatment of chronic refractory wounds

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056268
Enrollment
Unknown
Registered
2022-02-03
Start date
2021-09-13
Completion date
Unknown
Last updated
2024-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic refractory wounds

Interventions

Group 1:PRP treatment
Group 2:Sterile dressing covering and dressing change

Sponsors

The Affiliated Hospital of Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with basic medical diseases who are in stable condition after standardized medical diagnosis and treatment after admission; 2. After wound dressing change, debridement and negative pressure sealing drainage for at least 4 weeks, the wound showed no signs of improvement or aggravating trend; 3. Patients who have not used immunosuppressants and have not taken anticoagulants recently.

Exclusion criteria

Exclusion criteria: 1. Patients with mental illness, lack of insight and unable to express themselves accurately, and those with poor compliance; 2. Patients with blood disease, serious cardiovascular disease and sepsis; 3. Hemoglobin < 110 g / L, platelet PLT < 50 x 10^9/L, hematocrit < 33%; 4. Pregnant and lactating women; 5. Thrombin allergy.

Design outcomes

Primary

MeasureTime frame
Area of the unhealed wound size;Time of wound healing;

Countries

China

Contacts

Public ContactHaiyan Wang

The Affiliated Hospital of Qingdao University

why_phd@163.com+86 18661807327

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026